James Fandl
Senior Vice President
Protein Expression Science
Regeneron
Ireland
Biography
James P. Fandl, PhD, joined Regeneron in 1989 as Scientist in the Protein Expression Group. During his tenure at Regeneron, Dr. Fandl has held numerous positions; he was appointed Vice President of Protein Expression Sciences in 2001 and Senior Vice President of Protein Expression Sciences in 2015. His research group developed the VelociMab® suite of proprietary technologies, including EESYR®, FASTR™, NICE® and BST, which enabled Dr. Fandl to demonstrate his knack for acronyms. He received his AB in Biology from Franklin & Marshall College and his PhD in Microbiology from the University of California, Davis.
Research Interest
He has lead many leadership positions in the pharmaceutical industry and medical device company.
